Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Kaposi's sarcoma and its associated herpesvirus
Kaposi's sarcoma (KS) is the most common cancer in HIV-infected untreated individuals.
Kaposi's sarcoma-associated herpesvirus (KSHV; also known as human herpesvirus 8 …
Kaposi's sarcoma-associated herpesvirus (KSHV; also known as human herpesvirus 8 …
Herpes simplex virus 1 infection of neuronal and non-neuronal cells elicits specific innate immune responses and immune evasion mechanisms
Alphaherpesviruses (α-HV) are a large family of double-stranded DNA viruses which cause
many human and animal diseases. There are three human α-HVs: Herpes Simplex Viruses …
many human and animal diseases. There are three human α-HVs: Herpes Simplex Viruses …
[KNYGA][B] Pathology and genetics of tumours of soft tissue and bone
CDM Fletcher, KK Unni, F Mertens - 2002 - books.google.com
This WHO classification covers tumors of soft tissue and bone including inherited tumor
syndromes. Each entity is extensively discussed with information on clinicopathological …
syndromes. Each entity is extensively discussed with information on clinicopathological …
KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine
D Ganem - The Journal of clinical investigation, 2010 - jci.org
The linkage of Kaposi sarcoma (KS) to infection by a novel human herpesvirus (Kaposi
sarcoma–associated herpesvirus [KSHV]) is one of the great successes of contemporary …
sarcoma–associated herpesvirus [KSHV]) is one of the great successes of contemporary …
Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) epidemiology and pathogenesis
LA Dourmishev, AL Dourmishev… - Microbiology and …, 2003 - journals.asm.org
Kaposi's sarcoma had been recognized as unique human cancer for a century before it
manifested as an AIDS-defining illness with a suspected infectious etiology. The discovery of …
manifested as an AIDS-defining illness with a suspected infectious etiology. The discovery of …
Kaposi sarcoma: a continuing conundrum
RA Schwartz, G Micali, MR Nasca, L Scuderi - Journal of the American …, 2008 - Elsevier
Kaposi sarcoma (KS) remains a challenge. Its classic or Mediterranean form tends to be
benign. In transplant recipients it may be less so. As part of the AIDS pandemic, of which it …
benign. In transplant recipients it may be less so. As part of the AIDS pandemic, of which it …
KSHV infection and the pathogenesis of Kaposi's sarcoma
D Ganem - Annu. Rev. Pathol. Mech. Dis., 2006 - annualreviews.org
Kaposi's sarcoma (KS) has long been suspected of having an infectious etiology on the
basis of its unusual epidemiology, histopathology, and natural history. Nearly a decade ago …
basis of its unusual epidemiology, histopathology, and natural history. Nearly a decade ago …
Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover
B Glaunsinger, D Ganem - Molecular cell, 2004 - cell.com
The stimulation of host gene expression by lytic gene products of Kaposi's sarcoma-
associated herpesvirus (KSHV) has been proposed to play a critical role in KS development …
associated herpesvirus (KSHV) has been proposed to play a critical role in KS development …
Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection
Like cancer cells, virally infected cells have dramatically altered metabolic requirements. We
analyzed global metabolic changes induced by latent infection with an oncogenic virus …
analyzed global metabolic changes induced by latent infection with an oncogenic virus …
Immune deficiency and risk for malignancy among persons with AIDS
SM Mbulaiteye, RJ Biggar, JJ Goedert… - JAIDS Journal of …, 2003 - journals.lww.com
Background People with AIDS have an elevated risk for cancer. We studied the relationship
between cancer risk and AIDS-related immunosuppression as measured by CD4 count at …
between cancer risk and AIDS-related immunosuppression as measured by CD4 count at …